5-Azactidine is safe and effective therapy for prevention of disease relapse in high-risk patients with acute myeloid leukemia and myelodysplastic syndrome following allogeneic stem-cell transplantation

被引：0
|
作者：
Danylesko, Ivetta [1 ]
Shem-Tov, Noga [1 ]
Del-Giglio, Adriana [1 ]
Yerushalmi, Ronit [1 ]
Nagler, Arnon [1 ]
Shimoni, Avichai [1 ]
机构：
[1] Chaim Sheba Med Ctr, Ramat Gan, Israel
来源：
BONE MARROW TRANSPLANTATION | 2019年 / 54卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
O148
引用
收藏
页码：116 / 117
页数：2
相关论文
共 50 条
  • [1] Maintenance 5-Azactidine May Improve Outcomes after Allogeneic Stem-Cell Transplantation in High-Risk AML and MDS Patients
    Danylesko, Ivetta
    Shem-Tov, Noga
    Yerushalmi, Ronit
    Nagler, Arnon
    Shimoni, Avichai
    BLOOD, 2019, 134
  • [2] Maintenance 5-Azactidine May Improve Outcomes after Allogeneic Stem-Cell Transplantation in High-Risk AML and MDS Patients
    Danylesko, Ivetta
    Shem-Tov, Noga
    Yerushalmi, Ronit
    Nagler, Arnon
    Shimoni, Avichai
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S179 - S180
  • [3] Prospective Evaluation of Azacitidine Maintenance Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients with High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome
    Gill, Harinder
    Lie, Albert Kwok Wai
    Kwong, Yok Lam
    Leung, Anskar Y. H.
    BLOOD, 2015, 126 (23)
  • [4] Sequential Allogeneic Stem Cell Transplantation in High Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome
    Zavrelova, Alzbeta
    Radocha, Jakub
    Lanska, Miriam
    Zak, Pavel
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S312 - S312
  • [5] Allogeneic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes and Prevention of Relapse
    Franke, Georg-Nikolaus
    Luckemeier, Philipp
    Platzbecker, Uwe
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (01): : 1 - 7
  • [6] Stem cell therapy - indications to allogeneic transplantation in myelodysplastic syndrome and acute myeloid leukemia
    Beelen, D. W.
    ONKOLOGIE, 2012, 35 : 110 - 111
  • [7] Allogeneic stem cell transplantation for patients with high-risk myelodysplastic syndrome
    Hsu, C
    Lin, MT
    Tang, JL
    Tien, HF
    Wang, CH
    Chen, YC
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 1999, 98 (03) : 157 - 164
  • [8] On behalf of the SFGM-TC: prophylactic donor lymphocyte infusion in patients treated with allogeneic stem-cell transplantation for high-risk myelodysplastic syndrome and acute myeloid leukemia
    Guisnel, Charles
    Schirmer, Luciane
    Morisset, Stephane
    Robin, Marie
    Labussiere-Wallet, Helene
    Dulery, Remy
    Ceballos, Patrice
    Forcade, Edouard
    Nguyen-Quoc, Stephanie
    Poire, Xavier
    Maertens, Johan
    Chantepie, Sylvain
    Chevallier, Patrice
    Daguindau, Etienne
    Villate, Alban
    Charbonnier, Amandine
    Castilla-Llorente, Cristina
    Contentin, Nathalie
    Huynh, Anne
    Yakoub-Agha, Ibrahim
    Bulabois, Claude-Eric
    Rubio, Marie-Therese
    D'Aveni, Maud
    ACTA HAEMATOLOGICA, 2023, 146 (03) : 230 - 239
  • [9] Maintenance therapy with decitabine after allogeneic hematopoietic stem cell transplantation to prevent relapse of high-risk acute myeloid leukemia
    Ma, Yunju
    Qu, Changju
    Dai, Haiping
    Yin, Jia
    Li, Zheng
    Chen, Jia
    Qiu, Huiying
    Sun, Aining
    Miao, Miao
    Fu, Chengcheng
    Jin, Zhengming
    Zhu, Xiaming
    Wu, Depei
    Tang, Xiaowen
    BONE MARROW TRANSPLANTATION, 2020, 55 (06) : 1206 - 1208
  • [10] Maintenance therapy with decitabine after allogeneic hematopoietic stem cell transplantation to prevent relapse of high-risk acute myeloid leukemia
    Yunju Ma
    Changju Qu
    Haiping Dai
    Jia Yin
    Zheng Li
    Jia Chen
    Huiying Qiu
    Aining Sun
    Miao Miao
    Chengcheng Fu
    Zhengming Jin
    Xiaming Zhu
    Depei Wu
    Xiaowen Tang
    Bone Marrow Transplantation, 2020, 55 : 1206 - 1208
12345